Search results
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Argentina | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Australia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Austria | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Belgium | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Bulgaria | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Canada | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Chile | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | China | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Colombia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Croatia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Czech Republic | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Denmark | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Estonia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Finland | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | France | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Germany | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Greece | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Hungary | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Ireland | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Italy | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Japan | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Lithuania | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Mexico | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | New Zealand | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Norway | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Philippines | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Poland | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Portugal | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Romania | Rx | ~Filmed tablet ~Box with 2 PVC-PVdC/Al blisters of 14 film-coated tablets./5 and 80 mg per day of simvastatin, administered orally, as a single dose in the evening./the maximum dose used was 3.6 g. |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Russia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Singapore | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Slovak Republic | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Slovenia | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | South Korea | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Spain | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Sweden | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Switzerland | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | The Netherlands | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | 2004 | UK | OTC | Simvastatin 10mg switched to pharmacy status for use in conjunction with necessary lifestyle changes to reduce the risk of a first major coronary event in people likely to be at a moderate risk (approximately 10-15% 10-year risk of a first major event) of coronary heart disease (CHD)). Maximum strength 10mg, maximum daily dose 10mg, maximum pack size 28 tablets. Not currently marketed under OTC. |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | USA | Rx | — |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | Venezuela | Rx | — |
- 41 ingredients